Active Ingredient(s):Bromocriptine Mesylate FDA Approved: * May 5, 2009 Pharm Company: *VEROSCIENCE LLC Category:Hyperprolactinaemia
Bromocriptine, originally marketed as Parlodel and subsequently under many brand names, is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and, as an adjunct, type 2 diabetes.
It was patented in 1968 and approved for medical use in 1975.
1 Medical uses
2 Side effects
* May have multiple approval dates, manufacturers, or labelers. 4 Discussions